Elevated plasma levels of soluble P-selectin in patients with acute myocardial infarction and unstable angina. An inverse link to lipoprotein(a)

International Journal of Cardiology

Volumn 64, Issue 3, 1998, Pages 253-258

  Xu, Dan Yan ^a   Zhao, Shui Ping ^a   Peng, Wei Ping ^a  

^a Second Affil Hosp   (China)

Author keywords

Acute coronary event; Lipoprotein(a); P selectin

Indexed keywords

LIPOPROTEIN A; PADGEM PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; P-SELECTIN; STATISTICS, NONPARAMETRIC;

EID: 0032524787     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00075-8     Document Type: Article

References (28)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 262:1993;801-809.
2. Dore M., Korthuis R.J., Cranger D.N., Entman M.L., Smith C.W. P-selectin mediates spontaneous leukocyte rolling in vivo. Blood. 82:1993;1308-1316.
3. Lowrence M.B., Springer T.A. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 65:1991;859-873.
4. Lorant D.E., Topham M.K., Whatley R.E.et al. Inflammatory roles of P-selectin. J Clin Invest. 92:1993;559-570.
5. Johnson R.R., Mcgregor L., Taylor P.R., Poston R.N. Increase in adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques, coexpression with intercellular adhesion molecule-1. Am J Pathol. 144:1994;952-961.
6. Gauthior T.W., Scalia R., Murohara T., Ping G.I., Lefer A.M. Nitric oxide protects against leukocyte-endothelium interactions in the early states of hypercholesterolemia. Arterioscler Thromb Vasc Biol. 15:1995;1652-1659.
7. Lehr H.A., Olofsson A.M., Carew T.E.et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 71:1994;380-386.
8. Takeda I., Kaise S., Nishimiki T., Kasukawa R. Soluble P-selectin in the plasma of patients with connective tissue disease. Int Arch Allergy Appl Immunol. 105:1994;128-134.
9. Katayama M., Handa M., Araki Y.et al. Soluble P-selectin is present in normal circulation and its plasma levels are elevated in patients with thrombotic thrombocytopeanic purpura and haemolytic uraemic syndrome. Br J Haematol. 84:1993;702-710.
10. Mehta J.L., Nicolini F.A., Donnelly W.H., Nichols W.W. Platelets-leukocyte-endothelial interaction in coronary artery disease. Am J Cardial. 69:1992;8B-13B.
11. McEver R.P., Beckstead J.H., Moore K.L., Marshall C.L., Bainton D.F. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibei-Palade bodies. J Clin Invest. 84:1989;92-99.
12. Jilma B., Eichler H.G., Vondrovec B.et al. Effects of desmopressin on circulating P-selectin. Br J Haematol. 93:1996;432-436.
13. Buja L.M., Willerson J.T. Role of inflammation in coronary plaque disruption. Circulation. 89:1994;358-363.
14. Langford R.J., Wainwright R.J., Martin J.F. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol. 16:1996;51-55.
15. Ikeda H., Takajo Y., Ichiki K.et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation. 92:1995;1693-1696.
16. Wu G.X., Li F.G., Li P.X., Ruan C.G. Detection of plasma alpha-granule membrane protein GMP-140 using radiolabeled monoclonal antibodies in thrombotic disease. Haemostasis. 23:1993;121-128.
17. Schror K. Antiplatelet drugs: a comparative review. Drugs. 50:1995;7-28.
18. Langford E.J., Brawn A.S., Wainwright R.J.et al. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet. 344:1994;1458-1460.
19. Scanu A.M., Fless G.M. Lipoprotein(a): heterogeneity and biological relevance. J Clin Invest. 85:1990;1909.
20. Hajjar K.A., Gavish D., Braslow J.L., Nachman R.L. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature. 339:1989;302-305.
21. Melle E., Ibovnik A., Steinmetz A., Kostner G.M., Sattler W. Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets. Arterioscler Thromb. 14:1994;345-352.
22. Malle E., Sattler W. Platelets and the lipoproteins: native, modified and platelet modified lipoproteins. Platelets. 5:1994;70-83.
23. Gries A., Gries M., Warm H.et al. Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes. Arterioscler Thromb Vasc Biol. 16:1996;648-655.
24. Malle E., Sattler W., Prenner E. Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations. Atherosclerosis. 88:1991;193-201.
25. Horie H., Takahashi M., Lzumi M.et al. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty. Circulation. 96:1997;166-173.
26. Sattler W., Kosmer G.M., Weag G., Esterbauer H. Oxidation of lipoprotein(a): a comparison with low density lipoproteins. Biochim Biophys Acta. 1081:1991;65.
27. Naruszewicz N., Selinger E., Davignon J. Oxidative modification of lipoprotein(a) and the effect of β-carotene. Metabolism. 41:1992;1215.
28. Fortmann S.P., Marcovina S.M. Lipoprotein(a), a clinically elusive lipoprotein particle. Circulation. 95:1997;295-296.